417 related articles for article (PubMed ID: 17557238)
1. [Study on clinical features and fluorescence in situ hybridization detections of 22q11 microdeletion syndrome].
Qin YF; Yang JB; Xie CH; Shao J; Zhao ZY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):284-7. PubMed ID: 17557238
[TBL] [Abstract][Full Text] [Related]
2. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
[TBL] [Abstract][Full Text] [Related]
3. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between 22q11 microdeletion syndrome and congenital heart disease].
Qin YF; Xie CH; Yang JB; Wu DW; Shao J; Zhao ZY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jul; 39(7):631-5. PubMed ID: 22088244
[TBL] [Abstract][Full Text] [Related]
5. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
[TBL] [Abstract][Full Text] [Related]
6. Microdeletion 22q11 and oesophageal atresia.
Digilio MC; Marino B; Bagolan P; Giannotti A; Dallapiccola B
J Med Genet; 1999 Feb; 36(2):137-9. PubMed ID: 10051013
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies.
Beauchesne LM; Warnes CA; Connolly HM; Ammash NM; Grogan M; Jalal SM; Michels VV
J Am Coll Cardiol; 2005 Feb; 45(4):595-8. PubMed ID: 15708709
[TBL] [Abstract][Full Text] [Related]
8. [Improvement of genetic diagnostic strategy in velo-cardio-facial syndrome].
Pânzaru M; Rusu C; Voloşciuc M; Braha E; Butnariu L; Ivanov I; Grămescu M; Popescu R; Caba L; Sireteanu A; Macovei M; Covic M; Gorduza EV
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):756-61. PubMed ID: 22046783
[TBL] [Abstract][Full Text] [Related]
9. Genetic background of congenital conotruncal heart defects--a study of 45 families.
Kwiatkowska J; Wierzba J; Aleszewicz-Baranowska J; Ereciński J
Kardiol Pol; 2007 Jan; 65(1):32-7; discussion 38-9. PubMed ID: 17295158
[TBL] [Abstract][Full Text] [Related]
10. Deletion of 22q11 in two brothers with different phenotype.
Kasprzak L; Der Kaloustian VM; Elliott AM; Shevell M; Lejtenyi C; Eydoux P
Am J Med Genet; 1998 Jan; 75(3):288-91. PubMed ID: 9475599
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
Oh AK; Workman LA; Wong GB
Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
[TBL] [Abstract][Full Text] [Related]
13. Inherited t(9;22) as the cause of DiGeorge syndrome: a case report.
Shuib S; Abdul Latif Z; Abidin NZ; Akmal SN; Zakaria Z
Malays J Pathol; 2009 Dec; 31(2):133-6. PubMed ID: 20514857
[TBL] [Abstract][Full Text] [Related]
14. [DiGeorge syndrome, a review of 52 patients].
Minier F; Carles D; Pelluard F; Alberti EM; Stern L; Saura R
Arch Pediatr; 2005 Mar; 12(3):254-7. PubMed ID: 15734119
[TBL] [Abstract][Full Text] [Related]
15. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
[TBL] [Abstract][Full Text] [Related]
16. DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization.
Kornfeld SJ; Zeffren B; Christodoulou CS; Day NK; Cawkwell G; Good RA
J Allergy Clin Immunol; 2000 May; 105(5):983-7. PubMed ID: 10808180
[TBL] [Abstract][Full Text] [Related]
17. Differential detection of deletion 22q11.2 syndrome by specialty and indication.
Katzman PJ; Wang B; Sawhney M; Wang N
Pediatr Dev Pathol; 2005; 8(5):557-67. PubMed ID: 16222476
[TBL] [Abstract][Full Text] [Related]
18. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
[TBL] [Abstract][Full Text] [Related]
19. [22q11.2 chromosome deletion and velo-cardio-facial syndrome in a patient with tetralogy of Fallot].
Morava E; Masszi G; Czakó M; Tóth G; Melegh B; Kosztolányi G
Orv Hetil; 2000 Aug; 141(34):1873-5. PubMed ID: 11006712
[TBL] [Abstract][Full Text] [Related]
20. Congenital heart defects and chromosomal anomalies including 22q11 microdeletion (CATCH 22).
Soares G; Alvares S; Rocha C; Teixeira MF; Mota MC; Reis MI; Feijó MJ; Lima MR; Pinto MR
Rev Port Cardiol; 2005 Mar; 24(3):349-71. PubMed ID: 15929620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
